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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects of consumers and health providers working in partnership, as an intervention to promote person-centred health
services.
B A C K G R O U N D
This reviewwill assess the effects of consumers andhealth providers
working in partnership, as an intervention to promote person-
centred health services. In this review, we define ‘working in part-
nership’ as consumers and health providers making decisions to-
gether, in formal group formats (such as committees, councils,
boards, or steering groups), about aspects of health service plan-
ning, delivery, or evaluation (or a combination), with the aim of
making health services person-centred (see Glossary of key terms
in Appendix 1). This review is being conducted concurrently with
a Cochrane Qualitative Evidence Synthesis (QES) entitled Con-
sumers and health providers working in partnership for the pro-
motion of person-centred health services: a co-produced qualita-
tive evidence synthesis (Merner 2019; Figure 1).
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Figure 1. Modified infographic comparing the Intervention effects review process (on the left) and the
Qualitative evidence synthesis review process (on the right (Kaufman 2011))
Description of the condition
Historical and theoretical context of working in
partnership for the promotion of person-centred care
Consumers and providers working in partnerships in healthcare
decision-making, is based on paradigms of recovery, empower-
ment, and human, democratic, or consumer rights. The mental
health consumer recovery and empowerment movement explicitly
utilises consumer experiential knowledge throughworking in part-
nership, to transform and innovate services and policies (Pelletier
2011). In some countries, the impetus for working in partnership
in decision-making at the health service level, in addition to the
point of care level (consultation or encounter), has been driven
by healthcare safety and quality standards and rights. For exam-
ple, the Australian National Safety and Quality Health Service
Standards mandate that health service organisations partner with
consumers in health governance, policy, and planning to design,
deliver, and evaluate healthcare systems and services ( ACSQHC
2017). The Australian Charter of Healthcare Rights states that
people using the Australian healthcare system have the right to
participate in decision-making and choices about their own care,
and about health service planning and policies (ACSQHC 2008).
Person-centred care definition and features
Worldwide, healthcare sectors are adopting person-centred prin-
ciples to enhance quality of care, and empower consumers to par-
ticipate in their care (Delaney 2018;Mockford 2012; Stone 2008;
Tritter 2003). There are various definitions of person-centred care,
and terms, such as individualised or personalised, and patient-
, family-, or user-centred care are conceptually similar (Greene
2012). Common to these terms and definitions is the provision of
health care that emphasises personhood and partnership (Hubbard
2007). This review adopts the following definition of person-cen-
tred care: ‘planning, delivery, and evaluation of health care that
is grounded in mutually beneficial partnerships among healthcare
providers, patients, and families’ (IPFCC 2012).
Person-centred care is an overarching concept or ethos, which has
often been implemented at the health service level. Its implemen-
tation may also affect interactions at the point of care in many
different ways. For instance, the Picker Institute identifies the fol-
lowing principles for person-centred care, which underpin inter-
ventions at point of care: respecting consumer preferences and val-
ues; providing emotional support, physical comfort, information,
communication, and education; continuity and transitions, co-
ordination of, and access to care; and involvement of the family
and friends (Picker Institute 1987). Person-centred care contrasts
with doctor-centred care, which is criticised for being paternalistic,
medically dominated, and illness oriented (Bardes 2012; Berwick
2009).
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Working in partnership for the promotion of person-
centred health services
Working in partnership may be a key intervention for the pro-
motion of person-centred health services. Working in partnership
may impact organisational leadership, strategic vision, consumer
involvement, measurement and feedback of consumer experience,
staff capacity building, incentives, accountability, and a culture
supportive of learning and change (Luxford 2011). Qualitative
research has identified that factors embedded within the broader
health service(s) and health system, and policies are important to
facilitate person-centred care in the consultation process (i.e. at
the point of care delivery (Batalden 2016; Leyshon 2015; Ogden
2017)).
At point of care, person-centred consultations typically have three
main features: eliciting and skilfully listening to the consumer’s
personal narrative; encouraging the consumer’s active partici-
pation in goal setting; and documenting goals (Moore 2017).
Interventions that support one or more of these features in-
clude shared decision-making (Legaré 2014), decision aids (Stacey
2017), personalised care planning (Coulter 2011), family-centred
care (Shields 2012), or family-initiated care escalation interven-
tions (Mackintosh 2017). These interventions promote person-
centred care by focusing on consumer involvement in the clinical
consultation process, which influences the responsiveness of care
delivery at the level of individual consumers. Interpersonal and
communication skills training of providers also helps to promote
person-centred care in the consultation process (Dwamena 2012;
Repper 2007).
In contrast, the current review will focus on the involvement of
consumers in partnership with health providers as one of the key
ways in which person-centred care can be promoted at the health
service level i.e. upstream, at a higher level than the point of care
(Figure 2).
Figure 2. Decision-making at different levels of the health system influences the person-centeredness of
health services.
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Description of the intervention
Defining working in partnership as an intervention
The Australian Commission for Safety and Quality in Health
Care defines partnerships as “healthcare organisations, healthcare
providers, and policymakers actively workingwith people who use
the healthcare system, to ensure that health information and ser-
vices meet people’s needs” (ACSQHC 2018). The World Health
Organization (WHO) further defines partnership “as a collabo-
rative relationship between two or more parties, based on trust,
equality, andmutual understanding, for the achievement of a spec-
ified goal. Partnerships involve risks as well as benefits, making
shared accountability critical” (WHO 2009). The WHO defini-
tion identifies partnerships as a form of collaboration. While ‘col-
laborate’ features on the participation spectrum (Arnstein 1969),
and partnerships are considered an emergent process (Wildridge
2004;Wolf 2017), working in partnership is a distinct type of col-
laboration that occurs over a sustained time span to allow for the
ongoing process of developing constructive relationships (Ocloo
2017). Hence, one-off consumer participation in collaborations,
even when they are intended to promote person-centred care at
the health service level, do not fit within the parameters of this
review (Armstrong 2018; Fucile 2017; McKenzie 2017).
We will include trials that evaluate the effects of working in part-
nership (i.e. collaborative relationships between at least one con-
sumer and health provider, meeting jointly and regularly in for-
mal group formats, to equally contribute to and collaborate in
real-time), on decisions intended to promote person-centred care
in one or more areas of a health service or services. These for-
mal group formats could include committees, councils, boards, or
steering groups, whichmeetmore than once (either for an ongoing
or time-limited duration) in real-time (face-to-face or virtually).
Purpose(s) of working in partnership
Promoting person-centred care at the health service level may be
achieved by working in partnership to set priorities, identify prob-
lems, design solutions, or implement initiatives that reorient the
responsiveness of health services towards the information and ser-
vice delivery needs and experiences of consumers (Figure 3). Part-
nership approaches to develop policies or identify and monitor
performance indicators may also influence person-centred care at
the health service level. Working in partnership on such decisions
may improve health service performance ratings of affordability,
physical accessibility, acceptability, safety, quality, service availabil-
ity, and accountability. Working in partnership may improve the
responsiveness of health services to the consumers who use them
ACSQHC 2011; Doyle 2013; Rathert 2012). Working in part-
nership on these decisional activities may result in changes that
promote person-centred health services.
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Figure 3. How working in partnership may influence person-centred care outcomes at the health service
level
In research, numerous terms connote working in partnership at
the health service level. Working in partnership underpins partic-
ipatory action research, co-production, user-centred design, expe-
rience-based design, and co-design (Batalden 2016; Cooke 2016;
Jun 2018; Sanders 2008). Common to these collaborative deci-
sion-making approaches, is that they empower consumers at the
health service level, and promote the shift from ‘user as subject’ to
‘user as partner’ (Sanders 2008). Partnership approaches to deci-
sion-making may reorient health services from a ‘provider-focus’
to a ‘patient-focus’ (Luxford 2011), and are frequently illustrated
by the maxim ‘nothing about me, without me’ (Berwick 2009;
Coulter 2011; Delbanco 2001; Nelson 1998).
Optimising partnership working
Ottmann and colleagues caution that engagement and participa-
tion of consumers alone, does not suffice to enable this shift. They
argue that to ensure truly collaborative decision-making, the con-
tribution of stakeholder voices requires monitoring and amplifi-
cation where necessary, in order to account for intrinsic power
imbalances (Ottmann 2011). For example, in their research, ad-
ministrative and operational ‘imperatives’ dominated consumers’
voices; to address this power imbalance, the researchers adopted
the role of consumer advocate (Ottmann 2011). We will conduct
a subgroup analysis that focuses on the effects of attempts to ad-
dress intrinsic power imbalances in preparation for partnerships,
for example, by providing a salary or financial reimbursement, ori-
entation, training, coaching, or support (via an advocate, facilita-
tor, moderator, or mentor).
How consumers are selected can also contribute to power imbal-
ances, for example, by handpicking or inviting ‘appropriate’ or ‘ac-
quiescent’ representatives, or by overlooking class or ethnic groups
fromwhom comments are seldomheard (Ocloo 2016). Therefore,
in subgroup analysis, we will consider themethods of recruitment,
and whether the researchers ensured the inclusion of a diverse con-
sumer or provider participant group (e.g. care-givers, vulnerable
people, range of health providers). Another power imbalance to be
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considered is whether the partnership is professionally dominated
(Ocloo 2016). We will conduct a subgroup analysis based on the
ratio of consumers to providers (e.g. consumer majority, provider
majority, or equal).
How the intervention might work
Working in partnership interventions might work by strengthen-
ing the demand responsiveness and local accountability of health
services, by including consumers in health service planning and
policy decision-making (Björkman Nyqvist 2017). Responsive-
ness and accountability require information about (1) the needs,
preferences, experiences, and priorities of consumers of the service,
as well as (2) ratings of health service(s), such as performance in-
dicators. Consumers and health providers working in partnership,
means that both consumer and provider perspectives are available,
and feed into health service decision-making.
Recent trials focusing on working in partnership vary in the frame
of reference for partnership decision-making. In some trials, the
consumers and health providers directly involved in the partner-
ship (the partnership participants) approach decision-making us-
ing their own experience as a point of reference (Björkman Nyqvist
2017; Ong 2017; Palmer 2015; Palmer 2016). In other trials, the
partnership participants are explicitly required to incorporate ad-
ditional information that has been gathered systematically, as part
of the trial, into their decision-making (Björkman 2009; Greco
2006; Gullo 2017; Waiswa 2016). This additional information
may include the broader health service user perspectives (demand
side), the broader provider perspectives (supply side), or health
performance information (see Figure 4).
Figure 4. ‘Working in partnership’ interventions alone and as a component of multi-component
interventions
We will differentiate between working in partnership as an inter-
vention on its own, which only incorporates the viewpoints of the
consumer and provider partnership participants into their deci-
sion-making; and working in partnership as part of a multi-com-
ponent intervention, in which partnership participants consider
additional information (e.g. demand side, supply side, or perfor-
mance information) that has been gathered systematically, as part
of the trial, into their decision-making.
Why it is important to do this review
The dominant rationale for conducting this effectiveness review
is that it will parallel a co-produced Cochrane QES as identified
above (Merner 2019). The Cochane QES will synthesise research
on the views and experiences of consumers and health providers,
and identify best practice principles for working in partnership.
Together, this review and the QES will aim to form a comprehen-
sive and cohesive assessment of the evidence on partnering. Trials
evaluating the effects of upstream interventions of consumer in-
volvement in developing health care policy, research, and services
have been synthesised in other systematic reviews (Hubbard 2007;
Nilsen 2006). A systematic review of the theory, barriers and en-
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ablers for consumer and public involvement across health, social
care and consumer safety is also planned (Ocloo 2017). How-
ever, no reviews have specifically evaluated the effects of consumers
working in partnership, as an intervention to promote person-
centred care at the health service level, which is the focus here.
An earlier review in this area explored the effects of involving con-
sumers in the planning and development of health care, but at that
time, there were no comparative or experimental studies available
(Crawford 2002). Crawford and colleagues identified that involv-
ing consumers contributed to changes to services. However, they
also noted that the effects of involvement on quality of care (acces-
sibility and acceptability of services) or impact on consumers’ satis-
faction, health, or quality of life, hadnot been examined (Crawford
2002). In the absence of trial evaluations, reviews based on research
in this upstream context have focused on consumer participation
and involvement predominantly as an agenda or aspiration, with
guidance based on case studies of one-off collaboration examples.
Sharma and colleagues identified that engaging people in part-
nerships, shared decision-making, and meaningful participation
in health system improvement, all promoted person-centred care
(Sharma 2015).
We are aware of recently conducted or planned trials in the area,
and so a systematic review is timely (Björkman 2009; Björkman
Nyqvist 2017; Boivin 2014; Greco 2006; Hanson 2014; Ong
2017; Palmer 2015; Palmer 2016; Waiswa 2016). The Cochrane
Consumers and Communication Group has also identified the
promotion and implementation of person-centred care as a prior-
ity review topic (Synnot 2018; Synnot 2019).
We are aware of a planned update for a Cochrane Review eval-
uating consumer engagement in research, policy, and healthcare
services, which is being updated by Wiles and colleagues (Nilsen
2006; Wiles 2018). Unlike the forthcoming Wiles review, which
focuses on all forms of consumer engagement (i.e. consult, involve,
collaborate and empower), we will limit our focus to partnership
approaches (i.e. collaborate - but with an ongoing or time-limited
duration, excluding one-off collaborations). We will also limit our
focus to decisional activities intended to promote person-centred
care in one or more areas of a health service(s), whereas, Wiles
2018 will focus on broader types of activities in all areas of research,
policy, and healthcare services (including public health and health
promotion).
By focusing on partnership activities, our review will contribute
to Cochrane’s growing evidence base for interventions to promote
person-centred care, which currently has an exclusive focus on
consumer participation in interventions occurring at the point of
care (Coulter 2015; Dwamena 2012; Legaré 2014; Mackintosh
2017; Repper 2007; Shields 2012; Stacey 2017).
O B J E C T I V E S
To assess the effects of consumers and health providers working in
partnership, as an intervention to promote person-centred health
services.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs), cluster-
RCTs, and quasi-RCTs (a trial in which randomisation is at-
tempted, but subject to potential manipulation, such as allocating
participants by day of the week, date of birth, or sequence of entry
into trial), as we anticipate that few, properly conducted RCTs
will have focused on consumers and health providers working in
partnership.
Types of participants
We will include trials in which the following groups are partici-
pants.
1. Consumer partnership participants. Consumer
partnership participants refers to people who are fulfilling an
advisory or representative role within the partnership. These
roles might include a consumer or patient representative;
consumer consultant; consumer with acute or chronic
condition(s), their caregiver or family member; community
members, general public or citizens; representatives, consultants,
or members of consumer organisations.
2. Health provider partnership participants. Health
provider partnership participants refers to people who are
fulfilling an advisory or representative role within the
partnership. These roles might include, for example: a clinician
(such as doctor, nurse, allied health, or community health worker
from any discipline), health service manager, supervisor or
administrator (including quality coordinators, chief executives,
etc.), health policy maker, or consumer liaison officer. As we are
interested in partnerships between consumers and health
providers, we will exclude partnerships in which health providers
take on the role of consumer, or partnerships between consumers
and providers who are primarily health researchers or academics.
3. Health service users and health service providers. Health
service users and health service providers refers to the consumers
and providers who are not directly involved in the partnership
intervention, but are participants in trials that evaluate the effects
of the partnership intervention.
The Wiles review will exclude multi-stakeholder partnerships
comprised of fewer than 50% consumers where the comparator
is no intervention (Wiles 2018). In this review, provided the aim
of the partnership is to promote person-centred care at the health
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service level, we will include multi-stakeholder partnerships that
include at least one consumer.
As long as the goal is to make decisions to promote person-centred
care; partnership groups may be multi-stakeholder. As long as they
include at least one consumer; partnerships may be committees
that develop in-service training or vocational education curricu-
lum directed towards post-registration or post-graduate level stu-
dents.
Types of interventions
We will include trials evaluating the effects of consumers and
health providers working in partnership as an intervention, to
make decisions with the aim of promoting person-centred care in
one or more areas of a health service or services. We will include
trials of working in partnership in formal groups that meet face-
to-face or virtually, more than once.
We define person-centred care as “planning, delivery, and evalua-
tion of health care that is grounded in mutually beneficial partner-
ships among healthcare providers, patients, and families” (IPFCC
2012). Examples of person-centred care decisions at the health
service level include: identify appropriate and responsive health-
care indicators; improve continuity or follow-up of care; service
(re)development, (re)design of physical spaces, or improve coor-
dination of care across providers and settings (or a combination).
We will include trials evaluating the effects of consumers and
providers working in partnership in formal groups or commit-
tees to develop in-service training or vocational education curricu-
lum directed towards post-registration or post-graduate level stu-
dents (i.e. student cohort likely to be existing providers, and there-
fore partnership intervention may influence person-centeredness
of health service).
We define health services as public or privately funded services
that provide direct care to consumers in primary (e.g. community
health centres, general practitioner practices, private practices, dis-
pensaries), secondary (e.g. specialist outpatient clinics), or tertiary
settings (e.g. hospitals). We will include home and residential ser-
vices only when they primarily provide health or nursing care (e.g.
home-based nursing services, nursing homes, residential rehabili-
tation services, or hospices).
Working in partnership has three key components (see Table 1):
(1) both consumer and provider participants meet (2) jointly in
a formal group format over time, to (3) to consider or make an
actual decision that relates to the person-centeredness of health
service(s).
We will assess three comparisons in this review. Comparisons 1
and 2 will assess the effects of partnership versus no partnership
(with no other differences between groups), while comparison 3
will compare the effects of different versions of partnership.
Comparison 1. Consumers and health providers working in
partnership compared to usual practice without partnership
(i.e. usual ways of decision-making may contain some but
not all key components of working in partnership).
Studies for this comparison answer the question: ‘compared to
usual practice without partnership, what is the effectiveness of
consumers and health providers working in partnership, as an in-
tervention?’. For example, ‘what is the effect of facilitated partner-
ship (intervention) compared to no partnership (usual practice)?’
illustrates this comparison (Palmer 2015).
Examples of usual practice may include:
• decision-making involves some consumer input, but
decisions are not made jointly;
• providers independently make decisions;
• decision-making meets some key components, but group
format is informal, meets once-off, or does not meet together in
real-time.
Comparison 2. Consumers and health providers working in
partnership, as part of a multi-component intervention,
compared to the same multi-component intervention without
consumers and health providers working in partnership.
Studies for this comparison answer the question: ‘what is the ef-
fectiveness of a multi-component intervention that includes con-
sumers and health providers working in partnership, compared
to the same multi-component intervention without partnership?
’. For example, ‘what is the effect of facilitated partnership plus
health service consumer (demand side) information (multi-com-
ponent intervention with partnership) compared to health service
consumer (demand side) information without partnership (same
multi-component intervention without partnership)?’ illustrates
this comparison (Greco 2006).
For example, a multi-component intervention may include co-
interventions, such as health service consumer or provider infor-
mation (demand and supply), or health service performance in-
formation (or both). Working in partnership would be part of one
multi-component intervention arm, but not the other.
Comparison 3. One form of consumers and health providers
working in partnership, compared to another form of
consumers and health providers working in partnership.
Studies for this comparison answer the question: ‘what is the ef-
fectiveness of one form of consumers and health providers work-
ing in partnership intervention compared with another form of
consumers and health providers working in partnership interven-
tion?’. For example, both groups have working in partnership in-
terventions that fulfil all key components, but the intervention
and comparator groups differ in the nature of a key feature, such
as partnership participant composition (ratio of consumers and
providers), or frequency (ongoing versus time limited), or format
(online format versus face-to-face) of the meetings. We are yet to
identify a study as an example of this comparison.
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Excluded interventions
We will exclude trials where the comparison does not enable us to
isolate the effects of consumers and providers working in partner-
ship. This may include:
• Consumers and health providers working in partnership as
part of a multi-component intervention compared to usual
practice, or
• Consumers and health providers working in partnership,
compared to an active control that does not include working in
partnership (i.e. comparator is a different intervention).
In these cases, the comparisons will not allow us to evaluate the
effect of working in partnership as an intervention, as the inter-
vention and comparator groups differ on more than just the part-
nership component. An example illustrative of an excluded com-
parison is, ‘what is the effect of health service consumer (demand
side) information plus partnership (multi-component interven-
tion with partnership) compared to no health service consumer
(demand side) information and no partnership (usual practice)?’
(Boivin 2014).
As working in partnership is a distinct type of collaboration that
occurs over time, we will exclude one-off collaborations involv-
ing consumers in group formats, even when they are intended to
promote person-centred care. We will exclude studies that involve
partnering with consumers for decision-making about an individ-
ual’s care or treatment. We will also exclude studies about part-
nering with consumers for health services research (planning, un-
dertaking, or disseminating research), including a health service’s
management of research (research funding panels, setting research
priorities, research ethics and research governance (Gray-Burrows
2018)).
We will exclude trials that examine committees that develop ed-
ucational programmes or training for pre-registration or under-
graduate students, as we are interested in working in partnership
as a strategy to promote person-centred health services and un-
dergraduate students may not yet be employed as providers, and
therefore less able to either directly or indirectly influence the per-
son-centeredness of the health service as part of the intervention
(Klein 1999).
As we are interested in consumer-provider partnerships, we will
exclude studies of researchers or academics working in partnership
with consumers if providers are not also partnership participants.
Similarly, wewill exclude studies inwhich researchers or academics
are working in partnership with health providers, if consumers are
not partnership participants.
There may be some trials that are included in this review and an-
other Cochrane Review in progress, Interventions for improving
medical students’ interpersonal communication in medical con-
sultations (Gilligan 2016).
Types of outcome measures
This is the first Cochrane review on this topic and so we will aim
to include a wide range of outcomes to inform future conceptual
development and research. It is also possible that we may identify
some outcomes that we did not anticipate at the protocol stage,
but whichwe feel should be included in the review because they are
important to consumers or health providers making a decision. If
this occurs, we will provide justification and the difference will be
reported in the ‘Differences between protocol and review’ section.
Primary outcomes
Health service alterations (changes to services resulting from
decisions)
• Addition, rationalisation, substitution, expansion, or
revision of health services (e.g. changes to policies, performance
indicators, resources, processes or systems, programmes, settings
(e.g. relocating a stroke rehabilitation service from the hospital to
the community), education, information, physical structures, or
culture or values of services)
Degree to which health service alterations reflect health
service user (trial participant) priorities (demand
responsiveness)
• Comparability of partnership decision(s) with health service
end user preference(s) or priorities
Health service user (trial participant) health service
performance ratings (local accountability)
• Physical accessibility, e.g. simplified appointment
procedures, extended opening times, transport to unit, parking,
signage, security
• Affordability
• Acceptability e.g. satisfaction, retention or disengagement
of existing consumers, attracting new consumers, appointment
attendance or nonattendance
• Safety
• Quality
• Accountability
Health service user (trial participant) ratings of health
service utilisation patterns
• Uptake of altered services or changes in coverage
Health service provider (trial participant) outcomes
• Satisfaction, staff engagement, retention or turnover, well-
being
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Adverse events
• Measures of complaints, harms, litigation, damage to health
service reputation, staff disengagement or turnover, increased
rate of consumer failure to attend appointments, etc.
Secondary outcomes
Resource use
• Cost (time, money) associated with decision-making
process (e.g. cost of organising and running meetings, training
(providers and consumers), remuneration, coordination, or
meeting space)
• Cost (time, money) associated with implementing new or
changes in service
Consumer (partnership participant) outcomes*
• Attendance and retention rates in formal group formats
• Preparedness to participate (e.g. feeling informed,
motivation or empowerment to be involved, attitudes towards
partnership, etc.)
• Experiences of participation (e.g. satisfaction, preferences,
knowledge, well-being, involvement, etc.);
• Adverse outcomes and experiences (e.g. isolation,
exploitation, uncertainty, conflict, decreased well-being,
disengagement from health service)
Provider (partnership participant) outcomes*
• Attendance and retention rates in formal group formats
• Preparedness to participate (e.g. feeling informed,
confidence, attitudes towards partnership, etc.)
• Experiences of participation (e.g. satisfaction, preferences,
job satisfaction, well-being, etc.)
• Adverse outcomes and experiences (e.g. dissatisfaction,
worsening attitudes towards consumers, emotional exhaustion,
work overload, decreased well-being, disengagement or resigning
from employment, and conflict)
Measures of partnership among provider and consumer
partnership participants*
• Degree of shared decision-making involvement, capacity
building, trust, etc
*likely to bemeasured for both the intervention and control groups
only in comparison 3 (e.g. in head-to-head comparison of part-
nership interventions).
We will not exclude studies based on the presence or absence of
outcomes reported.
Where more than one outcome measure is available in one trial
for the same outcome:
• We will select the primary outcome that has been identified
by the study authors.
• Where no primary outcome was identified, select the one
specified in the sample size calculation.
• If there are no sample size calculations, rank the effect
estimates (i.e. list them in order from largest to smallest) and
select the median effect estimate. Where there is an even number
of outcomes, we will select the outcome whose effect estimate is
ranked n/2, where n is the number of outcomes.
We will use the selection steps above to inform the statistical anal-
ysis (i.e. pooling, synthesis). However, it may be appropriate to
collect data on more than one outcome measure per category per
trial to inform descriptive and narrative findings. Where a study
reports multiple outcome measures for the same outcome, we will
extract all, and review authors will meet to discuss and identify
the outcome measure most relevant to person-centred health care
(whether objective or subjective).
Two review authors will independently assign the outcomes re-
ported in each included study to the review’s outcome categories,
and resolve any differences in categorisation by involving a third
review author.
Timing of outcome assessment
We will group time points into short-, medium-, and long-term
time points. For the purpose of meta-analysis, we will select one
time point for each outcome from each study. How the identified
time points will be grouped will be decided at review stage.
Main outcomes for ‘Summary of findings’ tables
We will report the following outcomes in the ‘Summary of find-
ings’ tables.
• Health service alterations (changes to services resulting
from decisions)
• Degree to which changed service reflects consumer research
participant priorities (demand responsiveness)
• Health service user (trial participant) ratings of health
service performance (local accountability)
• Health service user (trial participant) health service
utilisation patterns
• Resources associated with decision-making process
• Resources associated with implementing decisions (e.g.
changed services)
• Adverse events
Search methods for identification of studies
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Electronic searches
We will search the following electronic databases:
• The Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library, latest issue);
• MEDLINE Ovid (2000 to present);
• Embase Ovid (2000 to present);
• PsycINFO Ovid (2000 to present); and
• CINAHL EBSCO (2000 to present).
We will search online trial registers (ClinicalTrials.gov), and the
WHO International Clinical Trials Registry Platform ( ICTRP)
for ongoing and recently completed studies.
We present the strategy for MEDLINE Ovid in Appendix 2. We
will tailor these strategies to other databases and report them in
the review.
The qualitative review scoping searches of this topic show a pro-
liferation of studies about partnering with consumers published
after 2000. The definition of person-centred care has developed
considerably over the past decades to include aspects broader than
partnering with individuals during consultations. Our assessment
shows that a consistent and recognisable definition of working in
partnership to promote person-centred health services has been
used most often since 2000. We aim to assess and build the evi-
dence on what is currently accepted as partnering in the context of
person-centred health services. Therefore, in this review, we will
search from 2000 onwards to exclude older, conceptually incon-
sistent studies. Due to resource constraints, we will exclude pub-
lications in languages other than English.
Searching other resources
We will search relevant grey literature sources, such as websites
(e.g. the WHO, Health Quality Improvement Partnership UK,
Involve UK, Health Foundation UK, Beryl Institute, James Lind
Alliance, International Association for Public Participation, In-
stitute for Patient- and Family- Centered Care (formerly Picker
Institute Europe), Health Issues Centre Australia, Planetree, The
King’s Fund, Consumer HealthOrganisaiton of Canada, Candian
Institutes of Health Research (CIHR), and the patient group, One
Voice Patient & Family Advisory Council, Mayo Clinic USA).
We will contact experts in the field and authors of included studies
for advice on other relevant studies. We will also search reference
lists of included studies and relevant systematic reviews.
Data collection and analysis
Selection of studies
Two review authors will independently screen all titles and ab-
stracts identified from searches to determine which meet the in-
clusion criteria. We will retrieve in full text any papers identified
as potentially relevant by at least one review author. Two review
authors will independently screen full-text articles for inclusion or
exclusion, with discrepancies resolved by discussion, and by con-
sulting a third review author, if necessary, to reach consensus. We
will list all potentially relevant papers excluded from the review at
this stage as excluded studies, with reasons provided in the ‘Char-
acteristics of excluded studies’ table. We will also provide citation
details and any available information about ongoing studies, and
collate and report details of duplicate publications, so that each
study (rather than each report) is the unit of interest in the review.
We will report the screening and selection process in an adapted
PRISMA flow chart (Liberati 2009).
Data extraction and management
Two review authors will independently extract data from included
studies. Any discrepancies will be resolved by discussion until con-
sensus is reached, or in necessary, through consultation with a
third author. We will develop and pilot a data extraction form, us-
ing Cochrane Consumers and Communication’s data extraction
template. We will extract data on the following items: details of
the study (aim of intervention, study design, description of in-
tervention and comparison group; risk of bias items (random se-
quence generation, allocation sequence concealment, blinding of
participants and personnel, blinding of outcome assessment, com-
pleteness of outcome data, selective outcome reporting, and other
sources of bias; whether the study explicitly sought informed con-
sent or obtained ethics approval); criteria related to precision of
the study (e.g. use of a power calculation); reporting standards,
or whether the validity or reliability (or both) of outcome mea-
sures was addressed; funding source and the declaration of interests
for the primary investigators; details of consumers and providers
(numbers, where and how recruited, training, purpose of part-
nership); setting (country, region, health department, organisa-
tion or service type); see Table 2. One review author will enter
all extracted data into Review Manager 5; a second review author
will independently check for accuracy against the data extraction
sheets (Review Manager 2014).
Assessment of risk of bias in included studies
We will assess and report on the methodological risk of bias of
included studies in accordance with theCochrane Handbook for
Systematic Reviews of Interventions, and the Cochrane Consumers
and Communication guidelines, which recommend the explicit
reporting of the following individual elements for RCTs: random
sequence generation; allocation sequence concealment; blinding
(participants, personnel); blinding (outcome assessment); com-
pleteness of outcome data, selective outcome reporting (Higgins
2011; Ryan 2013).
For cluster-RCTs, we will also assess and report the risk of bias as-
sociated with an additional domain, selective recruitment of clus-
ter participants.
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We will assess and report quasi-RCTs as being at a high risk of bias
for random sequence generation.
Wewill consider blinding separately for different outcomes, where
appropriate (for example, blinding may have the potential to dif-
ferently affect subjective versus objective outcome measures). We
will judge each item as being at high, low, or unclear risk of bias
as set out in the criteria provided by Higgins 2011, and provide a
quote from the study report and a justification for our judgement
for each item in the ’Risk of bias’ table.
We will deem studies to be at the highest risk of bias if we score
them as at high or unclear risk of bias for either the sequence
generation or allocation concealment domains, based on growing
empirical evidence that these factors are particularly important
potential sources of bias (Higgins 2011).
In all cases, two review authors will independently assess the risk of
bias of included studies, resolving any disagreements by discussion,
to reach consensus. We will contact study authors for additional
information about the included studies, or for clarification of the
study methods, as required. We will incorporate the results of the
‘Risk of bias’ assessment into the review through standard tables,
systematic narrative description, and commentary about each of
the elements. We will provide an overall assessment of the risk of
bias of included studies and a judgment about the internal validity
of the review’s results.
Measures of treatment effect
For dichotomous outcomes, we will analyse data based on the
number of events and the number of people assessed in the inter-
vention and comparison groups. We will use these to calculate the
risk ratio (RR) and 95% confidence interval (CI). For continuous
measures, we will analyse data based on the mean, standard devi-
ation (SD), and number of people assessed for both the interven-
tion and comparison groups to calculate mean difference (MD)
and 95%CI. If theMD is reported without individual group data,
we will use this to report the study results. If more than one study
measures the same outcome using different tools, we will calculate
the standardised mean difference (SMD) and 95% CI using the
inverse variance method in Review Manager 5 (Review Manager
2014).
Unit of analysis issues
If we include cluster-RCTs, we will check for unit-of-analysis er-
rors. If we find errors, and sufficient information is available, we
will re-analyse the data using the appropriate unit of analysis, by
taking account of the intracluster correlation (ICC). We will ob-
tain estimates of the ICC by contacting authors of included stud-
ies, or impute them using estimates from external sources. If it
is not possible to obtain sufficient information to re-analyse the
data, we will report effect estimates and annotate unit-of-analysis
error.
Dealing with missing data
We will attempt to contact study authors to obtain missing data
(participant, outcome, or summary data). For participant data,
we will, where possible, conduct analysis on an intention-to-treat
basis; otherwise, data will be analysed as reported. We will report
on the levels of loss to follow-up and reasons, and assess this as a
source of potential bias.
For missing outcome or summary data, we will impute missing
data where possible, and report any assumptions in the review.
We will investigate, through sensitivity analyses, the effects of any
imputed data on pooled effect estimates.
Assessment of heterogeneity
We will examine the heterogeneity across studies, as it is antic-
ipated that there will be considerable differences in settings, in-
terventions, participants, and outcomes, and use this descriptive
analysis to determine the most appropriate groupings of studies
within each of the review’s main comparisons. Where studies are
considered similar enough (based on consideration of these fac-
tors) to allow pooling of data using meta-analysis, we will assess
the degree of heterogeneity by visual inspection of forest plots,
and by examining the Chi² test for heterogeneity. We will report
our reasons for deciding that studies were similar enough to pool
statistically. Heterogeneity will be quantified using the I² statistic.
An I² value of 50% or more will be considered to represent sub-
stantial levels of heterogeneity, but this value will be interpreted
in light of the size and direction of effects and the strength of the
evidence for heterogeneity, based on the P value from the Chi² test
(Higgins 2011). Where heterogeneity is present in pooled effect
estimates, we will explore possible reasons for variability by con-
ducting subgroup analysis.
Where we detect substantial clinical, methodological, or statistical
heterogeneity across included studies, we will not report pooled
results frommeta-analysis, but insteadwill use a narrative approach
to data synthesis. In this event, we will clearly report our reasons
for deciding that studies were too dissimilar to meta-analyse. We
will also attempt to explore possible clinical or methodological
reasons for this variation by grouping studies that have similar
populations, intervention features, andmethodological features to
explore differences in intervention effects.
Assessment of reporting biases
We will assess reporting bias qualitatively, based on the character-
istics of the included studies (e.g. if only small studies that indicate
positive findings are identified for inclusion), and if information
that we obtain from contacting experts and authors of studies sug-
gests that there are relevant unpublished studies.
If we identify sufficient studies (at least 10) for inclusion in the
review, we will construct a funnel plot to investigate small study
effects, which may indicate the presence of publication bias. We
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will formally test for funnel plot asymmetry, and choose the ap-
propriate test based on advice inHiggins 2011.When interpreting
the results, we will bear in mind that there may be several reasons
for funnel plot asymmetry.
Data synthesis
We will decide whether to meta-analyse data based on whether
the interventions in the included trials are similar enough in terms
of participants, settings, intervention, comparison, and outcome
measures to ensure meaningful conclusions from a statistically
pooled result. Due to the anticipated variability in the populations
and interventions of included studies, we will use a random-effects
model for meta-analysis.
We will include data from all randomised trials in meta-analysis,
regardless of their rating for sequence generation, but will conduct
sensitivity analyses, excluding those at unclear or high risk of bias,
to examine the robustness of the meta-analysis results to method-
ological limitations of the included studies.
The way in which studies are grouped for analysis will depend on
the number of included studies and the types of comparisons iden-
tified. For example, it may make sense to group the included stud-
ies that examine comparison 1 into high intensity usual practice
(i.e. where usual decision-making practice includes some (more
than one) but not all key components of working in partnership)
or low intensity usual practice (i.e. usual practice limited to just
one key component of working in partnership).
If we are unable to pool the data statistically using meta-analysis,
we will provide clear reasons for this decision, and will conduct
a narrative synthesis of results. We will present the major out-
comes and results, organised by intervention categories according
to the major types or aims (or both) of the identified interven-
tions. Depending on the assembled research, we may also explore
the possibility of organising the data by population, and explore
heterogeneity in the results by investigating the subgroups iden-
tified below. Within the data categories, we will explore the main
comparisons of the review:
• Partnership intervention versus usual practice (without
partnership).
• Multi-component intervention with partnership versus
multi-component intervention without partnership.
• One form of partnership intervention versus another.
Where studies assess the effects of more than one intervention,
we will compare each separately with usual practice, and with one
another.
Using the synthesised quantitative findings to supplement
the Cochrane qualitative evidence synthesis (QES)
We will use a sequential approach to integrate the findings of
this effectiveness review with the findings of the concurrent QES
(Harden 2018). We will finalise the aims and method of integra-
tion of the findings after the syntheses of the QES and this review
are both complete. Following the separate synthesis of the quan-
titative and qualitative data, we will integrate the findings from
each review to form part of the discussion of both of them. For
example, the effectiveness review may provide information on the
effects of partnership interventions on health service, provider, or
consumer outcomes. The findings of the QES could link with the
effectiveness review by providing contextual information on part-
nership approaches, and may help to explain why partnering does
(or does not) influence specific outcomes. We anticipate that the
QESwill highlight issues of commonality and differences between
the perceptions of health providers and consumers about person-
centred care that may help to interpret the results of the effective-
ness review. The QES may also identify outcomes that should be
measured in future trials.
We do not anticipate many included trials, and expect that there
will be considerably more qualitative studies in the forthcoming
QES (Merner 2019). It is possible that the discussion and inte-
gration of the findings of both reviews will need to focus more on
future research questions, but we aim to use both reviews, where
possible, to inform our understanding of the effectiveness of in-
terventions, and the implementation of partnering approaches.
Subgroup analysis and investigation of heterogeneity
If statistical subgroup analysis is not possible, which is likely, we
will use the possible explanatory factors outlined here to explore
the effects of interventions narratively.
Subgroup analyses will examine trials that explicitly attempt to
address intrinsic power imbalances in preparation for partnerships
(e.g. provision of salary or financial reimbursement, orientation,
training, coaching, or support (e.g. via an advocate, facilitator,
moderator, mentor, or consumer liaison officer) versus trials that
did not); the ratio of consumers to providers (consumer majority
versus provider majority); and the partnership duration (e.g. on-
going versus time-limited).
Sensitivity analysis
We will explore the impact of assumptions, imputed data, and the
inclusion of studies at high risk of bias by:
• Comparing the results of studies at higher and lower risk of
bias (remove from the analysis studies with a high or unclear
rating on the sequence generation item of the ‘Risk of bias’ tool
and see how robust the results are when based only on studies
with low risk of bias).
• Compare results based on imputed data, e.g. when ICC
values have been taken from external sources for cluster-RCTs.
‘Summary of findings’ table
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We will prepare a separate ‘Summary of findings’ table, using
GRADEpro software, to present the results of the meta-analysis
or narrative synthesis (or both) for each major comparisons of
the review, for the seven key outcomes outlined in the Types of
outcome measures section (GRADEpro GDT). We will provide
a source and rationale for each assumed risk cited in the table(s).
Two review authors will independently assess the quality of the
evidence, using the criteria described in Schünemann 2011, study
limitations, indirectness, imprecision, inconsistency, and report-
ing bias.
Ensuring relevance to decisions in health care
Both this protocol and the related QES protocol were co-designed
with a Stakeholder Advisory Panel who will also be directly in-
volved in the production of the QES at the review stage (Merner
2019). A draft of this current protocol was shared with the Stake-
holder Advisory Panel prior to a stakeholder workshop day. Dur-
ing the workshop, the stakeholders provided the following feed-
back on the protocol.
• Refine definitions to reflect practice e.g. consumers and
health providers often ‘make decisions together’ rather than
‘sharing responsibility for decisions’.
• Define terms in understandable, or lay language.
• A diagram or infographic showing the differences between
the effectiveness review and the QES is needed to help with
clarity.
• Explain the differences between point of care versus
partnership in health service.
• Clarify if Consumer Liaison Officer as a complaints role or
advocate role.
• Consider (in subgroup analyses) role of power differentials,
consumer representatives, whether led or chaired by consumer or
professional, who initiated the group, who leads partnerships,
and hierarchies within service (e.g. palliative care -
multidisciplinary care).
• Relevant outcomes might include: participatory outcomes,
such as cohesion or collaboration (perhaps in measures of
increasing involvement or capacity building); consumer
participation as stepping stone to higher-level participation and
involvement (i.e. capacity building, which benefits the individual
consumer and the system); and personal well-being. Decisions
might result in: changes in systems or services; improved
accessibility (of parking, signage, security and reduced theft);
more dissemination of changed services and outcomes;
rationalised services (i.e. increased focus on those that consumers
want, on those that add value); growth in services (i.e. may
demonstrate increased need); change of setting (e.g. hospital
service to community, hospital to home setting); staff
engagement, retention, etc; and financial cost savings (i.e. if
experienced staff stay on, this may be more cost-effective than
adding new staff ). Adverse events might include stakeholder
disengagement, negative impacts on reputation, noncompliance,
and failure to attend at point of care.
• Relevant grey literature search sites might include: Beryl
Institute, Health Foundation UK; work with First Nations
people has led the way with community-led engagement.
The Stakeholder Panel feedback resulted in the following changes
to this protocol.
• Changed ‘sharing responsibility for decisions’ to ‘make
decisions together’ or alternatively ‘jointly make decisions’.
• Glossary added to define terms (see Appendix 1).
• Modified the infographic of the funnel diagram to outline
the different steps in the qualitative and quantitative systematic
review approaches (see Figure 1).
• Developed figure to highlight the level of the health system
where partnership-based decision-making might impact the
person-centeredness of health services (i.e. national, state,
regional (policy) level, or local health service governance
(organisational) level, as opposed to the direct care (point of
care) level (see Figure 2)).
• Removed the term Consumer Liaison Officer as an example
in the background, and referred instead to a consumer advocate
role as a support component of facilitated partnerships.
• Added to the methods our intent to consider the identified
potential sub-group analyses, if number of included trials allows.
• Added the identified outcomes.
• Added the grey literature resources.
In addition, wewill discuss the findings fromboth reviewswith the
Stakeholder Panel.Wewill ask the panel to provide feedback on the
integration of the results of the effectiveness review with the QES.
We will also ask panel members for their input on the implications
of the results. Panel members suggested relevant organisations for
the dissemination stage, to ensure the protocol and review will
reach consumer, health provider, research, and policy networks.
A content expert will provide feedback on the protocol and review,
as part of Cochrane Consumers and Communication’s standard
editorial process.
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A D D I T I O N A L T A B L E S
Table 1. Key components of working in partnership versus usual practice
Key compo-
nents of work-
ing in partner-
ship
(1) Partnership participant types (2) Joint formal group format, meets over time (3) Decision re-
lates to person-
centeredness of
health service
Working in part-
nership as an in-
tervention
At least one con-
sumer
At least
one heath service
provider
Opportunity to
influence delib-
eration and deci-
sion-making by
meeting jointly
(e.g. f2f, online,
phone)
Formal group
format
(e.g. board, com-
mittee, council,
steering or work
group)
Meets more than
once
(e.g. time-lim-
ited or ongoing)
Joint decisions
about health
service planning,
delivery, or eval-
uation
Usual practice -
may con-
tain some, but
not all, key com-
ponents of work-
ing in partner-
ship
e.g. no consumer
participant, or
consumer(s) in-
volved, but not
in decision-mak-
ing
(or)
no health service
provider partici-
pant, or provider
(s) involved, but
not in decision-
making
(or) group does
not meet jointly
e.g. independent
deliberation and
decision-making
(or) group is in-
formal or ad-hoc
(or) group meets
only once
(or)
either the con-
sumer or health
service provider
participant pro-
vides feedback,
or acts in an ad-
visory or con-
sultative capac-
ity, rather than
decision-mak-
ing, for health
service planning,
delivery, or eval-
uation
f2f - face-to-face
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Table 2. Data extraction template
Citation
Name of review author completing this form
Date form completed
Notes (unpublished - for own
use)
e.g. references to be followed up, source of information (especially if multiple reports of same trial, or
unpublished data or personal communication included)
Notes(published) e.g. contact with author (Yes /No),
study translated from a language other than English, (Yes/No)
duplicate publication (Yes/No)
information or unpublished data obtained (Yes/No)
Notes(published) e.g. study has qualitative data
A. Details of study Supporting text Additional notes or queries
Study design (RCT, cluster-RCT)
Aim of study (as stated in the trial report/s.
What was the trial designed to as-
sess?)
Aim of intervention
(if different from study aim)
(as stated in the trial report/s.
What was the problem that this
intervention was designed to ad-
dress?)
Methods of recruitment of par-
ticipants
(How were potential participants
approached and invited to partic-
ipate?)
Funding (including source, amount, if
stated)
Sample size/power calculation (Was a calculation described, and
were participants recruited to
meet it?)
Consumer involvement (e.g. in design of study, interven-
tion, or both; in delivery of in-
tervention; in evaluation of inter-
vention; in interpretation of study
findings)
Declaration of interests for the
primary investigators
(conflict of interests)
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Table 2. Data extraction template (Continued)
B. Location and setting Supporting text Additional notes or queries
Geographical location (State/province and country)
Degree of regional development (urban/rural)
Type of healthcare system if described
(universal access (taxation or so-
cial insurance), voluntary insur-
ance, individual out-of-pocket,
specified access for low income,
immigrant, or refugee patients)
Context of healthcare system (public, government funded or
privately funded services in pri-
mary care, hospital setting, or
community clinics)
C. Participants Supporting text Additional notes or queries
Inclusion/exclusion criteria for
participation in study
(providers and consumers) Have
important populations or groups
been excluded from the study (e.
g. people with more than one
concurrent health problem (mul-
timorbidity) or disability, those
from any socioeconomic groups)?
Number (eligible, excluded, refused to take
part, randomised to interven-
tion, randomised to control, ex-
cluded post-randomisation (with
reasons), withdrawn, lost to fol-
low-up, died, included in analy-
sis, included for each outcome)
Intervention:
Control:
Received intervention (proportion of those allocated to
intervention who received it)
Consumer Supporting text Additional notes or queries
Categorisation (caregiver, consumer, community
member)
Age range (including standard deviation)
Gender (female only/male only/mixed/
unclear)
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Table 2. Data extraction template (Continued)
Level of education (if reported)
Socioeconomic status (as described by the study)
Diagnosis (if reported)
Other (e.g. literacy or reading level; pre-
vious partnership experience)
Provider Supporting text Additional notes or queries
Categorisation (GP; allied health worker, etc)
Age range (including standard deviation)
Gender (female only/male only/mixed/
unclear)
Level of education (if reported)
Socioeconomic status (as described by the study)
Number of years practicing (if reported)
Other (e.g. previous partnership experi-
ence)
D. Intervention Supporting text Additional notes or queries
Intervention name & number
of groups
(list all for each intervention
group)
Intervention purpose (including author’s terminology
re: partnering and person cen-
tred-care)
Context of partnering (describe formal committee or
group e.g. autonomous, semi-au-
tonomous, government controlled
board or body; governance com-
mittee; community advisory; pa-
tient council; co-design; co-pro-
duction; quality and safety com-
mittee; feedback from, experience
of committee)
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Table 2. Data extraction template (Continued)
Was the partnering tailored,
modified, adapted?
(if so, describe what was done and
why)
Was training provided to part-
ners?
(if so, describe what was done and
why)
Format or delivery mode of
meeting
(face-to-face, online, telephone;
note: must be real-time)
Partnership duration (ongoing or time-limited)
Frequency of partnership meet-
ings
(must be more than once)
Duration of meetings (e.g. average, total length of time
meeting)
Deliverer (who was responsible for organ-
ising (researchers; management;
etc); host organisation)
Location of meetings (onsite at health setting; other lo-
cation)
Type of decision-making activ-
ity
(discuss, approve budget; set pri-
orities; identify problems; de-
sign solutions; implement initia-
tives; develop policies; identify
andmonitor performance indica-
tors; other?)
Decision-making process, at-
tempts to resolve conflict
(e.g. consensus, vote, agreement,
etc.)
Diversity of consumer and
provider participants
(e.g. caregivers, vulnerable peo-
ple, range of health providers)
Ratio of consumers to providers (e.g. consumer majority; con-
sumer minority; equal)
Attempts to address intrinsic
power imbalances
(e.g. provision of salary or finan-
cial reimbursement, orientation,
training, coaching or support e.g.
via an advocate, facilitator, mod-
erator, mentor, or consumer liai-
son officer)
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Table 2. Data extraction template (Continued)
Theoretical basis for interven-
tion
(if described)
Fidelity, integrity (Was the intervention delivered as
intended? record any assessment of
this)
Details of control, usual, or rou-
tine care
Details of co-interventions in
all groups
(co-interventions may be sepa-
rate to the intervention of inter-
est for this review, or they may be
other similar elements in a suite of
interventions having a common
purpose. Record all relevant infor-
mation)
E. Primary outcomes Supporting text Additional notes or queries
Additional outcomes measured
by study
(List all outcomes measured by the
study, which do not apply to any
of the chosen review primary and
secondary outcomes)
Primary outcome 1 (repeat for each primary outcome)
Outcome measured (Yes/no)
Description of outcome assessment tool
Validity and reliability of outcome measure
Methods of follow-up for non-respondents
Number of outcome assessments
Timing of outcome assessment (including frequency and length
of follow-up)
F. Secondary outcomes Supporting text Additional notes or queries
Secondary outcome 1 (repeat for each secondary outcome)
Outcome measured (Yes/no)
Description of outcome assessment tool
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Table 2. Data extraction template (Continued)
Validity and reliability of outcome measure
Methods of follow-up for non-respondents
Number of outcome assessments
Timing of outcome assessment (including frequency and length
of follow-up)
G. Study conclusion Supporting text Additional notes or queries
Conclusion drawn by study au-
thors
(Where details are not included
in the published study, or are un-
clear, we will contact authors)
H. ’Risk of bias’ assessment Review authors’ judgment Judgment and supporting
text
Additional notes or queries
Random sequence generation Describe the method used to gen-
erate the allocation sequence in
sufficient detail to allow an assess-
ment of whether it should produce
comparable groups
(high risk, low risk, unclear)
Allocation concealment
(to intervention)
Describe the method used to
conceal the allocation sequence
in sufficient detail to determine
whether intervention allocations
could have been foreseen in ad-
vance of, or during, enrolment
(high risk, low risk, unclear)
Blinding of participants and
personnel
(for each main outcome)
Describe all measures used, if
any, to blind study participants
and personnel from knowledge of
which intervention a participant
received. Provide any informa-
tion relating to whether the in-
tended blinding was effective.
participants
(high risk, low risk, unclear)
Personnel
(high risk, low risk, unclear)
Blinding of outcome assess-
ment
(for each main class of outcome)
Describe all measures used, if
any, to blind outcome assessors
from knowledge of which inter-
vention a participant received.
Provide any information relating
to whether the intended blinding
was effective. If the outcome is ob-
jective (e.g. length of hospital stay)
the rating should be low risk.
(high risk, low risk, unclear)
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Table 2. Data extraction template (Continued)
Incomplete outcome data
(for each main outcome)
Describe the completeness of out-
come data for eachmain outcome,
including attrition and exclusions
from the analysis. State whether
attrition and exclusions were re-
ported, the numbers in each inter-
vention group (compared with to-
tal randomised participants), rea-
sons for attrition and exclusions
where reported, and any re-inclu-
sions in analyses performed by the
review authors.
(high risk, low risk, unclear)
Selective reporting State how the possibility of selec-
tive outcome reporting was exam-
ined by the review authors, and
what was found. This is likely to
be ’unclear’, unless a protocol is
provided for the trial. Also report
if any outcome is mentioned, but
the results are not reported.
(high risk, low risk, unclear)
Other sources of bias examples: contamination; base-
line imbalance not explained by
previously mentioned categories;
blocked randomisation in un-
blinded trials. Note, this is not
a judgment on quality of trial.
Themain risk of bias concerns for
cluster-RCTs are: (i) recruitment
bias (differential participant re-
cruitment in clusters for different
interventions); (ii) baseline im-
balance; (iii) loss of clusters; (iv)
incorrect analysis; and (v) com-
parability with individually ran-
domised trials.
(high risk, low risk, unclear)
(added) Selective recruitment
of participants (cluster-RCTs)
Recruitment bias can occur when
individuals are recruited to the
trial after the clusters have been
randomised, as the knowledge of
whether each cluster is an ‘inter-
vention’ or ‘control’ cluster could
affect the types of participants re-
cruited.
(high risk, low risk, unclear)
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A P P E N D I C E S
Appendix 1. Glossary of key terms
Consumer partnership participant(s): refers to people who are fulfilling an advisory or representative role within the partnership.
These roles might include a consumer or patient representative; consumer consultant; consumer with acute or chronic condition(s),
their carer, or family member; community members, general public, or citizens; representatives, consultants, or members of consumer
organisations.
Facilitated partnership: assistance is provided (e.g. by researchers, consumer advocates, or others) to help partnership participants to
work in partnership (e.g. provide training or support before, or moderate or advocate during meetings).
Formal group format: refers to an organised group, such as a committee, council, board, or steering group.
Health services: defined as public or privately funded services that provide direct care to consumers in primary (e.g. community health
centres, general practitioner practices, private practices, dispensaries), secondary (e.g. specialist outpatient clinics), or tertiary settings
(e.g. hospitals). We will include home and residential services only when they primarily provide health or nursing care (e.g. home-based
nursing services, nursing homes, residential rehabilitation services, or hospices).
Health service performance information (as an added intervention): data are collected about the performance of health service beyond
that experienced by partnership participants (i.e. could be information about a measure of service quality at baseline, or performance in
relation to other services), and provided to partnership participants for consideration during decision-making. Alternatively, consumer
and provider partnership participants independently generate health service performance indicator ratings before meeting as a group.
Health service user or provider (demand or supply side) information (as an added intervention): data are collected about the needs,
preferences, experiences, or priorities of the people who use (demand side), or who provide (supply side) the health service, beyond
those who are partnership participants (i.e. additional information is gathered systematically from health service users and providers as
part of the trial), and provided to partnership participants for consideration during decision-making.
Intervention effects review: in a systematic review of intervention effects, the researchers aim to locate, assess the risk of bias, and
synthesise all of the available evidence related to a specific research question about the effects of an intervention. In this case, the
question is ‘what are the effects of consumers and providers working in partnership to promote person-centred health services’?
Partnership at health service level (i.e. upstream, at a higher level than the point of care): consumer and health providers jointly plan,
develop, and monitor health services at the national, state, or regional policy or organisational governance level.
Parternship at point of care: refers the clinical consultation (or encounter) level during which individual health practitioner(s) interact
with individual patient(s) to jointly plan and manage their own health care, sometimes called the direct care level (can include more
than one consumer and provider interacting in self-management groups). Partnerships at the point of care level are excluded from this
review.
Provider partnership participant(s): refers to people who are fulfilling an advisory or representative role within the partnership. These
roles might include, for example: a clinician (such as a doctor, nurse, allied health, or community health worker from any discipline),
health service manager, supervisor, or administrator (including quality co-ordinators, chief executives, etc.), health policy maker, or
consumer liaison officer. Health provider participants do not include people who are primarily health researchers or academics.
Qualitative evidence synthesis: in a systematic review of qualitative evidence, the researchers aim to locate, assess the methodological
quality, and synthesise evidence related to a specific research question about the experience of a phenomenon. When combined with
an intervention effects review, the qualitative evidence synthesis aims to help understand how the intervention works, for whom, and
in what context, and how best to implement it (Flemming 2019). In this case, the question is ‘what are the barriers, facilitators, and
experiences of consumers and providers working in partnership to promote person-centred health services’?
Working in partnership (as an intervention): defined as a joint meeting of at least one consumer and health provider, which occurs
more than once, in a formal group format, to make decisions together, with the aim of promoting person-centred care in one or more
areas of a health service or services. The group is to meet face-to-face or virtually (i.e. meet in real-time, on an ongoing or time-limited
basis).
27The effects of consumers and health providers working in partnership as an intervention for the promotion of person-centred health
services (Protocol)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. MEDLINE search strategy
1. exp Community Participation/
2. Stakeholder Participation/
3. Decision Making/
4. exp Patient-Centered Care/
5. ((patient* or communit* or consumer* or user* or carer* or caregiver* or client* or famil* or lay*) adj3 (decid* or decision* or
engag* or involv* or participat*)).ti,ab,kf.
6. or/1-5
7. ”Health Priorities“/
8. exp Patient Care Team/
9. exp Ambulatory Care Facilities/
10. *”Mental Health Services“/
11. *”Community Health Services“/
12. *”Health Services Administration“/
13. ”Quality Improvement“/
14. *”Hospitals, Public“/
15. ”Quality of Health Care“/
16. ”Delivery of Health Care“/
17. ”Delivery of Health Care, Integrated“/
18. or/7-17
19. ”Community-Institutional Relations“/
20. ”Advisory Committees“/og
21. (partner* or participat* or consult* or decision* or deliberation* or co#design* or involv* or contribut* or role* or empower* or
engag* or collab* or advoca* or organi#ation* or respons*).ti,ab,kf.
22. (experience based adj2 design).ti,ab,kf.
23. or/19-22
24. randomized controlled trial.pt.
25. controlled clinical trial.pt.
26. randomized.ab.
27. placebo.ab.
28. drug therapy.fs.
29. randomly.ab.
30. trial.ab.
31. groups.ab.
32. or/24-31
33. Non-Randomized Controlled Trials as Topic/
34. ((cluster or quasi) adj3 trial*).tw.
35. or/33-34
36. exp animals/ not humans.sh.
37. 32 not 36
38. 35 not 36
39. limit 37 to (english language and yr=”2000 -Current“)
40. limit 38 to (english language and yr=”2000 -Current“)
41. and/6,18,23,39
42. and/6,18,23,40
43. or/41-42
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N O T E S
This protocol is based on standard text and guidance provided by Cochrane Consumers and Communication (Ryan 2016).
30The effects of consumers and health providers working in partnership as an intervention for the promotion of person-centred health
services (Protocol)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
